Identification and functional characterization of Penicillium marneffei major facilitator superfamily (MFS) transporters

Biosci Biotechnol Biochem. 2020 Jul;84(7):1373-1383. doi: 10.1080/09168451.2020.1732185. Epub 2020 Mar 12.

Abstract

is a thermally dimorphic fungus that causes penicilliosis, and become the third-most-common opportunistic fungal infection in immunocompromised patients in Southeast Asia. Azoles and amphotericin B have been introduced for the treatment, however, it is important to investigate possible mechanisms of azole resistance for future treatment failure. We identified 177 putative MFS transporters and classified into 17 subfamilies. Among those, members of the Drug:H+ antiporter 1 subfamily are known to confer resistance to antifungals. Out of 39 paralogs, three (encoded by PmMDR1, PmMDR2, and PmMDR3) were heterologously overexpressed in S. cerevisiae AD∆ conferred resistance to various drugs and compounds including azoles, albeit to different degrees. PmMDR1-expressing strain showed resistance to the broadest range of drugs, followed by the PmMDR3, and PmMDR2 conferred weak resistance to a limited range of drugs. We conclude that PmMDR1 and PmMDR3, may be able to serve as multidrug efflux pumps.

Keywords: Saccharomyces cerevisiae; DHA subfamily; Major facilitator superfamily (MFS) transporter; multidrug resistance; rug efflux pump.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / chemistry*
  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • ATP Binding Cassette Transporter, Subfamily B / metabolism*
  • Amino Acid Sequence
  • Amphotericin B / pharmacology*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / pharmacology*
  • Asia, Southeastern / epidemiology
  • Candida albicans / drug effects
  • Candida albicans / metabolism
  • Drug Resistance, Fungal / drug effects
  • Humans
  • Immunocompromised Host
  • Microbial Sensitivity Tests
  • Mycoses / drug therapy
  • Mycoses / epidemiology
  • Mycoses / metabolism*
  • Mycoses / microbiology
  • Phylogeny
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / metabolism
  • Saccharomyces cerevisiae Proteins / genetics
  • Talaromyces / drug effects
  • Talaromyces / metabolism*
  • Transcriptome
  • Triazoles / pharmacology*
  • Triazoles / therapeutic use

Substances

  • ATP Binding Cassette Transporter, Subfamily B
  • Antifungal Agents
  • Saccharomyces cerevisiae Proteins
  • Triazoles
  • Amphotericin B

Supplementary concepts

  • Talaromyces marneffei